gland pharma: Gland Pharma stocks fall 2% after profits announcement

New Delhi, stocks fell 2% in Tuesday morning buying and selling after the corporate reported a decline in third-quarter internet source of revenue. Stocks fell 1.87% to Rs 1,351.65 a percentage in early buying and selling at the BSE.

At the NSE, stocks fell 1.93% to Rs 1,349.05 a percentage.

The 30-share BSE Sensex used to be up 134.96 issues, or 0.22% upper, at 61,076.63 in morning buying and selling.

Gland Pharma Ltd on Monday reported a fifteen % decline in consolidated internet source of revenue to Rs 231.95 crore for the 1/3 quarter ended December 2022 because of manufacturing delays because of provide disruptions.

The corporate’s consolidated internet source of revenue used to be Rs 273.03 crore for a similar duration final fiscal 12 months, the corporate mentioned in a observation.

Consolidated running earnings for the reporting quarter used to be Rs 938.29 crore in comparison to Rs 1,063.33 crore final 12 months.

General spending within the 1/3 quarter used to be down Rs 688.95 crore from Rs 743.43 crore in the similar duration a 12 months in the past.